52.55

0.07% -0.08

Soleno Therapeutics Inc (SLNO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$52.63

Offen:

$52.63

24-Stunden-Volumen:

253.67K

Relative Volume:

0.08

Marktkapitalisierung:

$2.72B

Einnahmen:

$190.41M

Nettoeinkommen (Verlust:

$20.48M

KGV:

235.86

EPS:

0.2228

Netto-Cashflow:

$46.66M

1W Leistung:

+0.66%

1M Leistung:

+55.81%

6M Leistung:

-18.17%

1J Leistung:

-21.77%

1-Tages-Spanne:

$52.53

$52.64

1-Wochen-Bereich:

$52.21

$52.69

52-Wochen-Spanne:

$29.43

$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Firmenname

Soleno Therapeutics Inc

Sektor

Healthcare (1108)

Branche

Biotechnology (623)

Telefon

650-213-8444

Adresse

100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA

Mitarbeiter

182

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

SLNO's Discussions on Twitter

Compare SLNO vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SLNO Soleno Therapeutics Inc	52.55	2.72B	190.41M	20.48M	46.66M	0.2228
VRTX Vertex Pharmaceuticals Inc	435.32	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	751.04	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	800.53	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.40	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	310.52	34.37B	5.36B	287.73M	924.18M	2.5229

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-18	Eingeleitet	Wolfe Research	Outperform
2025-10-07	Eingeleitet	Goldman	Buy
2025-08-20	Eingeleitet	Wells Fargo	Overweight
2025-06-23	Eingeleitet	TD Cowen	Buy
2025-03-05	Fortgesetzt	Stifel	Buy
2024-12-02	Bestätigt	Robert W. Baird	Outperform
2024-12-02	Bestätigt	Stifel	Buy
2024-09-03	Eingeleitet	H.C. Wainwright	Buy
2024-05-10	Eingeleitet	Robert W. Baird	Outperform
2024-02-05	Eingeleitet	Piper Sandler	Overweight
2024-01-23	Eingeleitet	Stifel	Buy
2023-11-21	Fortgesetzt	Guggenheim	Buy
2020-09-29	Eingeleitet	Guggenheim	Buy
2020-01-10	Eingeleitet	Craig Hallum	Buy
2019-12-23	Eingeleitet	Oppenheimer	Outperform
2018-02-13	Bestätigt	Maxim Group	Buy

Alle ansehen

Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten

03:48 AM

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

03:48 AM

Apr 12, 2026

SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - PR Newswire

Apr 12, 2026

Trading the Move, Not the Narrative: (SLNO) Edition - Stock Traders Daily

Apr 12, 2026

2026-04-12 | SLNO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:SLNO | Press Release - Stockhouse

Apr 12, 2026

Apr 11, 2026

NASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc. - The Globe and Mail

Apr 11, 2026

FinancialContentNASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc. - FinancialContent

Apr 11, 2026

SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com

Apr 11, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSLNO - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - PR Newswire

Apr 10, 2026

Neurocrine Biosciences, Inc. (NBIX) Soleno Therapeutics, Inc.M&A CallSlideshow (NASDAQ:NBIX) 2026-04-10 - Seeking Alpha

Apr 10, 2026

SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors ... - Bluefield Daily Telegraph

Apr 10, 2026

SLNO Shareholder Alert: Soleno Therapeutics, Inc. - GlobeNewswire

Apr 10, 2026

INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class ActionHagens Berman - Sahm

Apr 10, 2026

TD Cowen Downgrades Soleno Therapeutics to 'Hold' - National Today

Apr 10, 2026

Apr 09, 2026

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 09, 2026

SLNO DEADLINE NOTICE: Soleno Therapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP By May 5, 2026 - ACCESS Newswire

Apr 09, 2026

Rosen Law Firm Encourages Soleno Therapeutics Investors to Secure Counsel Before Deadline - National Today

Apr 09, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors with ... - Caledonian Record

Apr 09, 2026

ROSEN, A LEADING LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EOSE - GlobeNewswire Inc.

Apr 09, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire

Apr 09, 2026

SLNO Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com

Apr 09, 2026

SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire

Apr 09, 2026

Soleno Therapeutics Investors Seek Lead in Class Action Lawsuit - National Today

Apr 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesSLNO - PR Newswire

Apr 09, 2026